These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

313 related articles for article (PubMed ID: 8142045)

  • 21. Maturation pathway of nisin and other lantibiotics: post-translationally modified antimicrobial peptides exported by gram-positive bacteria.
    de Vos WM; Kuipers OP; van der Meer JR; Siezen RJ
    Mol Microbiol; 1995 Aug; 17(3):427-37. PubMed ID: 8559062
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The generation of nisin variants with enhanced activity against specific gram-positive pathogens.
    Field D; Connor PM; Cotter PD; Hill C; Ross RP
    Mol Microbiol; 2008 Jul; 69(1):218-30. PubMed ID: 18485077
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Bioengineering nisin to overcome the nisin resistance protein.
    Field D; Blake T; Mathur H; O' Connor PM; Cotter PD; Paul Ross R; Hill C
    Mol Microbiol; 2019 Mar; 111(3):717-731. PubMed ID: 30537404
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Sublichenin, a new subtilin-like lantibiotics of probiotic bacterium Bacillus licheniformis MCC 2512
    Halami PM
    Microb Pathog; 2019 Mar; 128():139-146. PubMed ID: 30594640
    [TBL] [Abstract][Full Text] [Related]  

  • 25. 'Bac' to the future: bioengineering lantibiotics for designer purposes.
    Molloy EM; Ross RP; Hill C
    Biochem Soc Trans; 2012 Dec; 40(6):1492-7. PubMed ID: 23176504
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Engineering a disulfide bond and free thiols in the lantibiotic nisin Z.
    van Kraaij C; Breukink E; Rollema HS; Bongers RS; Kosters HA; de Kruijff B; Kuipers OP
    Eur J Biochem; 2000 Feb; 267(3):901-9. PubMed ID: 10651829
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Dissection and modulation of the four distinct activities of nisin by mutagenesis of rings A and B and by C-terminal truncation.
    Rink R; Wierenga J; Kuipers A; Kluskens LD; Driessen AJ; Kuipers OP; Moll GN
    Appl Environ Microbiol; 2007 Sep; 73(18):5809-16. PubMed ID: 17660303
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Nisin Z, mutant nisin Z and lacticin 481 interactions with anionic lipids correlate with antimicrobial activity. A monolayer study.
    Demel RA; Peelen T; Siezen RJ; De Kruijff B; Kuipers OP
    Eur J Biochem; 1996 Jan; 235(1-2):267-74. PubMed ID: 8631341
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Intensive mutagenesis of the nisin hinge leads to the rational design of enhanced derivatives.
    Healy B; Field D; O'Connor PM; Hill C; Cotter PD; Ross RP
    PLoS One; 2013; 8(11):e79563. PubMed ID: 24244524
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Nisin, a peptide antibiotic: cloning and sequencing of the nisA gene and posttranslational processing of its peptide product.
    Kaletta C; Entian KD
    J Bacteriol; 1989 Mar; 171(3):1597-601. PubMed ID: 2493449
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Specificity of Subtilin-Mediated Activation of Histidine Kinase SpaK.
    Geiger C; Spieß T; Korn SM; Kötter P; Entian KD
    Appl Environ Microbiol; 2017 Sep; 83(18):. PubMed ID: 28710266
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Lantibiotics, class I bacteriocins from the genus Bacillus.
    Lee H; Kim HY
    J Microbiol Biotechnol; 2011 Mar; 21(3):229-35. PubMed ID: 21464591
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Engineering dehydrated amino acid residues in the antimicrobial peptide nisin.
    Kuipers OP; Rollema HS; Yap WM; Boot HJ; Siezen RJ; de Vos WM
    J Biol Chem; 1992 Dec; 267(34):24340-6. PubMed ID: 1447185
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Discovery, Production and Modification of Five Novel Lantibiotics Using the Promiscuous Nisin Modification Machinery.
    van Heel AJ; Kloosterman TG; Montalban-Lopez M; Deng J; Plat A; Baudu B; Hendriks D; Moll GN; Kuipers OP
    ACS Synth Biol; 2016 Oct; 5(10):1146-1154. PubMed ID: 27294279
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Lantibiotics: promising candidates for future applications in health care.
    Dischinger J; Basi Chipalu S; Bierbaum G
    Int J Med Microbiol; 2014 Jan; 304(1):51-62. PubMed ID: 24210177
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Nisin-relevant antimicrobial peptides: synthesis strategies and applications.
    Yuan L; Wu S; Tian K; Wang S; Wu H; Qiao J
    Food Funct; 2024 Sep; 15(19):9662-9677. PubMed ID: 39246095
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Autoregulation of subtilin biosynthesis in Bacillus subtilis: the role of the spa-box in subtilin-responsive promoters.
    Kleerebezem M; Bongers R; Rutten G; de Vos WM; Kuipers OP
    Peptides; 2004 Sep; 25(9):1415-24. PubMed ID: 15374645
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Structure-activity relationships in the peptide antibiotic nisin: antibacterial activity of fragments of nisin.
    Chan WC; Leyland M; Clark J; Dodd HM; Lian LY; Gasson MJ; Bycroft BW; Roberts GC
    FEBS Lett; 1996 Jul; 390(2):129-32. PubMed ID: 8706842
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Staphylococcus aureus Virulence Affected by an Alternative Nisin A Resistance Mechanism.
    Kawada-Matsuo M; Watanabe A; Arii K; Oogai Y; Noguchi K; Miyawaki S; Hayashi T; Komatsuzawa H
    Appl Environ Microbiol; 2020 Apr; 86(8):. PubMed ID: 32086306
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Determination of the sequence of spaE and identification of a promoter in the subtilin (spa) operon in Bacillus subtilis.
    Chung YJ; Hansen JN
    J Bacteriol; 1992 Oct; 174(20):6699-702. PubMed ID: 1400221
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.